Re: Schroeck et al.: Differential adoption of laser prostatectomy for treatment of benign prostatic hyperplasia (Urology 2013;81:1177-1183).
Vattikuti Urology Institute, Henry Ford Health System, Detroit, MI; Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada; Department of Urology, Ruhr University Bochum, Marienhospital, Herne, Germany; Department of Surgery, Division of Urology, Brigham and Women's Hospital / Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
Kirsten
K
Janosek-Albright
Florian
F
Roghmann
Joachim
J
Noldus
Maxine
M
Sun
Quoc-Dien
QD
Trinh
D006801:Humans; D053685:Laser Therapy / Q000191:economics*; D008297:Male; D011468:Prostatectomy / Q000191:economics* / Q000379:methods*; D011470:Prostatic Hyperplasia / Q000601:surgery*; D020728:Transurethral Resection of Prostate / Q000191:economics*